Gemcitabine and Nab-Paclitaxel Infusion Schedule for Metastatic Pancreatic Cancer
Phase 2
53
about 5.5 years
18+
1 site in OH
About this study
This trial is testing a new way to give gemcitabine and nab-paclitaxel, two chemotherapy drugs, to people with pancreatic cancer that has spread. The goal is to see if this schedule improves how well the treatment works.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Gemcitabine
- 2.Take Nab-paclitaxel
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
gemcitabine, paclitaxel (Taxane chemotherapy; stabilizes microtubules)
injection (Injection), infusion
Primary: Overall response rate (ORR)
Secondary: Disease control rate, Incidence of adverse events (AEs), Overall survival (OS), Progression-free survival (PFS)
Oncology